IDH1R132, IDH2R140 and IDH2R172 in AML: different genetic landscapes correlate with outcome and may influence targeted treatment strategies

Leukemia. 2018 May;32(5):1249-1253. doi: 10.1038/s41375-018-0026-z. Epub 2018 Jan 30.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Isocitrate Dehydrogenase
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / genetics*
  • Molecular Targeted Therapy / methods*
  • Receptors, Cell Surface
  • Treatment Outcome

Substances

  • Receptors, Cell Surface
  • IDH2 protein, human
  • Isocitrate Dehydrogenase
  • IDH1 protein, human